These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 16835629)

  • 1. Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives.
    Villa P; van Beek J; Larsen AK; Gerwien J; Christensen S; Cerami A; Brines M; Leist M; Ghezzi P; Torup L
    J Cereb Blood Flow Metab; 2007 Mar; 27(3):552-63. PubMed ID: 16835629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic window for nonerythropoietic carbamylated-erythropoietin to improve motor function following multiple infarct ischemic strokes in New Zealand white rabbits.
    Lapchak PA; Kirkeby A; Zivin JA; Sager TN
    Brain Res; 2008 Oct; 1238():208-14. PubMed ID: 18761001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO).
    Kirkeby A; Torup L; Bochsen L; Kjalke M; Abel K; Theilgaard-Monch K; Johansson PI; Bjørn SE; Gerwien J; Leist M
    Thromb Haemost; 2008 Apr; 99(4):720-8. PubMed ID: 18392330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of neuroprotective effects of erythropoietin (EPO) and carbamylerythropoietin (CEPO) against ischemia-like oxygen-glucose deprivation (OGD) and NMDA excitotoxicity in mouse hippocampal slice cultures.
    Montero M; Poulsen FR; Noraberg J; Kirkeby A; van Beek J; Leist M; Zimmer J
    Exp Neurol; 2007 Mar; 204(1):106-17. PubMed ID: 17157835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin and carbamylated erythropoietin are neuroprotective following spinal cord hemisection in the rat.
    King VR; Averill SA; Hewazy D; Priestley JV; Torup L; Michael-Titus AT
    Eur J Neurosci; 2007 Jul; 26(1):90-100. PubMed ID: 17614942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effect of erythropoietin, and role of metallothionein-1 and -2, in permanent focal cerebral ischemia.
    Wakida K; Shimazawa M; Hozumi I; Satoh M; Nagase H; Inuzuka T; Hara H
    Neuroscience; 2007 Aug; 148(1):105-14. PubMed ID: 17624681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in long-term beneficial effects of erythropoietin given after neonatal stroke in postnatal day-7 rats.
    Wen TC; Rogido M; Peng H; Genetta T; Moore J; Sola A
    Neuroscience; 2006; 139(3):803-11. PubMed ID: 16581190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin prevents long-term sensorimotor deficits and brain injury following neonatal hypoxia-ischemia in rats.
    Spandou E; Papadopoulou Z; Soubasi V; Karkavelas G; Simeonidou C; Pazaiti A; Guiba-Tziampiri O
    Brain Res; 2005 May; 1045(1-2):22-30. PubMed ID: 15910759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of a postischemic treatment with a bradykinin B2 receptor antagonist in a rat model of temporary focal cerebral ischemia.
    Lumenta DB; Plesnila N; Kläsner B; Baethmann A; Pruneau D; Schmid-Elsaesser R; Zausinger S
    Brain Res; 2006 Jan; 1069(1):227-34. PubMed ID: 16378603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective potential of erythropoietin and its derivative carbamylated erythropoietin in periventricular leukomalacia.
    Liu W; Shen Y; Plane JM; Pleasure DE; Deng W
    Exp Neurol; 2011 Aug; 230(2):227-39. PubMed ID: 21596035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin and its non-erythropoietic derivative: do they ameliorate renal tubulointerstitial injury in ureteral obstruction?
    Srisawat N; Manotham K; Eiam-Ong S; Katavetin P; Praditpornsilpa K; Eiam-Ong S
    Int J Urol; 2008 Oct; 15(11):1011-7. PubMed ID: 18759748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbamylated erythropoietin is neuroprotective in an experimental model of traumatic brain injury.
    Adembri C; Massagrande A; Tani A; Miranda M; Margheri M; De Gaudio R; Pellegrini-Giampietro DE
    Crit Care Med; 2008 Mar; 36(3):975-8. PubMed ID: 18176311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus, a potential neuroprotective agent, ameliorates ischemic brain damage and neurologic deficits after focal cerebral ischemia in nonhuman primates.
    Furuichi Y; Maeda M; Moriguchi A; Sawamoto T; Kawamura A; Matsuoka N; Mutoh S; Yanagihara T
    J Cereb Blood Flow Metab; 2003 Oct; 23(10):1183-94. PubMed ID: 14526229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nonerythropoietic asialoerythropoietin protects against neonatal hypoxia-ischemia as potently as erythropoietin.
    Wang X; Zhu C; Wang X; Gerwien JG; Schrattenholz A; Sandberg M; Leist M; Blomgren K
    J Neurochem; 2004 Nov; 91(4):900-10. PubMed ID: 15525344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies to improve post-stroke behavioral recovery in aged subjects.
    Buga AM; Bălşeanu A; Popa-Wagner A; Mogoantă L
    Rom J Morphol Embryol; 2009; 50(4):559-82. PubMed ID: 19942950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis.
    Savino C; Pedotti R; Baggi F; Ubiali F; Gallo B; Nava S; Bigini P; Barbera S; Fumagalli E; Mennini T; Vezzani A; Rizzi M; Coleman T; Cerami A; Brines M; Ghezzi P; Bianchi R
    J Neuroimmunol; 2006 Mar; 172(1-2):27-37. PubMed ID: 16337691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia.
    Wang Y; Zhang ZG; Rhodes K; Renzi M; Zhang RL; Kapke A; Lu M; Pool C; Heavner G; Chopp M
    Br J Pharmacol; 2007 Aug; 151(8):1377-84. PubMed ID: 17603558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed treatment with aminoguanidine decreases focal cerebral ischemic damage and enhances neurologic recovery in rats.
    Nagayama M; Zhang F; Iadecola C
    J Cereb Blood Flow Metab; 1998 Oct; 18(10):1107-13. PubMed ID: 9778187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High dose erythropoietin promotes functional recovery of rats following facial nerve crush.
    Zhang W; Sun B; Yu Z; An J; Liu Q; Ren T
    J Clin Neurosci; 2009 Apr; 16(4):554-6. PubMed ID: 19231194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term protective effect of atorvastatin in permanent focal cerebral ischemia.
    Yrjänheikki J; Koistinaho J; Kettunen M; Kauppinen RA; Appel K; Hüll M; Fiebich BL
    Brain Res; 2005 Aug; 1052(2):174-9. PubMed ID: 16023089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.